Cellect Biotechnology (Cellect Biotechnology) Other Current Liabilities : $0.00 Mil (As of Jun. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Cellect Biotechnology Other Current Liabilities?

Cellect Biotechnology's other current liabilities for the quarter that ended in Jun. 2021 was $0.00 Mil.

Cellect Biotechnology's quarterly other current liabilities increased from Sep. 2020 ($-0.00 Mil) to Dec. 2020 ($-0.00 Mil) and increased from Dec. 2020 ($-0.00 Mil) to Jun. 2021 ($0.00 Mil).

Cellect Biotechnology's annual other current liabilities stayed the same from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($0.00 Mil) but then declined from Dec. 2019 ($0.00 Mil) to Dec. 2020 ($-0.00 Mil).

Cellect Biotechnology Other Current Liabilities Historical Data

The historical data trend for Cellect Biotechnology's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellect Biotechnology Other Current Liabilities Chart

Cellect Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Current Liabilities

Get a 7-Day Free Trial

Cellect Biotechnology Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Jun21
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cellect Biotechnology Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Cellect Biotechnology Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Cellect Biotechnology's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellect Biotechnology (Cellect Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellect Biotechnology Ltd (NAS:APOP) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Hata’as Street, Kfar Saba, ISR, 44425

Website

http://www.cellect.co

Cellect Biotechnology Ltd is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies. The company is developing its first product based on its ApoGraft technology platform, the ApoTainer kit that utilizes FasL- apoptotic protein.